lobbying_activities: 2020101

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2020101	9c8a346f-6978-4fdd-885c-a69de13adc3a	Q3	CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.	8511	GLOBAL HEALTHY LIVING FOUNDATION	2017	third_quarter	HCR	Real World Evidence Patient Reported Outcomes Hatch Waxman Amendments to the Food and Drug Cosmetic Act Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2017-10-05T16:24:34.897000-04:00